| BMC Pulmonary Medicine | |
| Characteristics and prognostic implications of peripheral blood lymphocyte subsets in patients with anti-MDA5 antibody positive dermatomyositis-interstitial lung disease | |
| Research | |
| Ting Li1  Zhi-Ling Zhao1  Lin Feng1  Dong Wang1  Zhao-Hui Tong1  Xue-Lei Zang2  Lan Gao2  Xin-Ying Xue2  Ya-Wen Shen2  Fang-Ping Ren2  Qi Chen2  Wei-Chao Zhao3  Shan-Shan Yao4  Xin-Yu Bao5  Si-Wei Gu6  | |
| [1] Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China;Beijing Shijitan Hospital, Capital Medical University, Beijing, China;PLA Strategic Support Force Medical Center, Beijing, China;University of Pittsburgh, Pittsburgh, USA;Weifang Medical College, Weifang, China;Xuanwu Hospital, Capital Medical University, Beijing, China; | |
| 关键词: Anti-melanoma differentiation-associated gene 5; Dermatomyositis; Interstitial lung disease; Lymphocyte subsets; Prognostic; | |
| DOI : 10.1186/s12890-023-02706-y | |
| received in 2023-06-19, accepted in 2023-10-11, 发布年份 2023 | |
| 来源: Springer | |
PDF
|
|
【 摘 要 】
ObjectivesTo examine the characteristics of blood lymphocyte subsets in dermatomyositis-interstitial lung disease (DM-ILD) inflicted patients with positive anti-melanoma differentiation-associated gene 5 (anti-MDA5), as well as its prognosis value in this set of patients.MethodsData were retrospectively collected from 253 DM-ILD patients from three hospitals in China between January 2016 to January 2021. Patients were grouped into anti-MDA5 antibody positive group (MDA5+ DM-ILD) and anti-MDA5 antibody negative group (MDA5− DM-ILD) based on myositis-specific autoantibody test results. Demographic characteristics, lymphocyte subsets patterns and other clinical features were compared between the two groups. The association of lymphocyte subsets with 180-day mortality was investigated using survival analysis in MDA5+ DM-ILD.ResultsOut of 253 eligible patients with DM-ILD, 59 patients were anti-MDA5+ and 194 were anti-MDA5−. Peripheral blood lymphocyte count, CD3+ count, percentage of CD3+, CD3+CD4+ count, and CD3+CD8+ count was lower in MDA5+ DM-ILD than in MDA5− DM-ILD− (all P < 0.001) as well as CD3−CD19+ count (P = 0.04). In MDA5+ DM-ILD, CD3+CD8+ count ≤ 49.22 cell/μL (HR = 3.81, 95%CI [1.20,12.14]) and CD3-CD19+ count ≤ 137.64 cell/μL (HR = 3.43, 95%CI [1.15,10.24]) were independent predictors of mortality. CD3+CD8+ count ≤ 31.38 cell/μL was associated with a higher mortality risk in all DM-ILD patients (HR = 8.6, 95%CI [2.12,31.44]) after adjusting for anti-MDA5 and other clinical characteristics.ConclusionSignificant lymphocytes decrease was observed in MDA5+ DM-ILD patients. CD3+CD8+ cell count was associated with worse prognosis in both MDA5+ DM-ILD and all DM-ILD patients.
【 授权许可】
CC BY
© The Author(s) 2023
【 预 览 】
| Files | Size | Format | View |
|---|---|---|---|
| RO202311103867073ZK.pdf | 1386KB | ||
| 40517_2023_273_Article_IEq4.gif | 1KB | Image | |
| 12864_2017_3527_Article_IEq9.gif | 1KB | Image | |
| MediaObjects/12902_2023_1474_MOESM1_ESM.docx | 28KB | Other | |
| MediaObjects/12888_2023_5278_MOESM2_ESM.docx | 20KB | Other | |
| 12951_2015_155_Article_IEq23.gif | 1KB | Image |
【 图 表 】
12951_2015_155_Article_IEq23.gif
12864_2017_3527_Article_IEq9.gif
40517_2023_273_Article_IEq4.gif
【 参考文献 】
- [1]
- [2]
- [3]
- [4]
- [5]
- [6]
- [7]
- [8]
- [9]
- [10]
- [11]
- [12]
- [13]
- [14]
- [15]
- [16]
- [17]
- [18]
- [19]
- [20]
- [21]
- [22]
- [23]
- [24]
- [25]
- [26]
- [27]
- [28]
- [29]
- [30]
- [31]
- [32]
- [33]
- [34]
- [35]
- [36]
- [37]
PDF